Search results
Shark Tank India: If you’re a fan of “Shark Tank India,” you’ll enjoy these other shows that delve...
The Times of India· 19 hours agoEntrepreneurs pitch their business ideas to a panel of venture capitalists, affectionately referred...
Emcure has better listed pharma alternatives
The Economic Times· 4 hours agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical market. The...
Man recovering from shark bite on the Florida coast in state's third attack in a month
Hindustan Times· 2 days agoOfficials from the Nassau County Sheriff’s Office Marine Unit responding to a distress call Friday...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 2 hours agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Watch: Woman Conquers Her Fear Of Sharks By Swimming With Them - News18
News18· 1 hour agoMost of us would not imagine voluntarily swimming around sharks. Muthi Annuriy was on a trip to...
Watch a Great White Shark Check Out a Paddleboarding T-Rex
The Inertia· 1 day agoA guy in a T-Rex suit on a paddleboard unwittingly cruised around with a great white shark. That's...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 2 hours agoThe initial public offering (IPO) of Emcure Pharmaceuticals opens for bidding on Wednesday, July 3...
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO
The Economic Times· 2 days agoShark Tank fame Namita Thapar, part of the promoter group of Emcure Pharmaceuticals, will make...
Shark Tank India Judge Namita Thapar On Trying To Strike Work-Life Balance - News18
News18· 6 days agoShark Tank India judge Namita Thapar often grabs headlines for her opinions. Most recently, she...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 19 hours agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...